Health ministry proposes sweeping changes to India’s drug licensing policy
The health ministry has proposed overarching changes to its drug licensing program for uniformity across India that would boost drug safety. The proposal follows a government expert panel emphasizing the need for uniform implementation of documentation and dossier-based approval processes for drugs manufactured in the country to ensure consistent quality and safety.
Why it’s important: The move comes after cough syrups made in India were linked to deaths of children overseas. India must protect its reputation of being the world’s pharmacy through stricter controls. Moneycontrol